Amarin to formulate Parkinson's drug for Acadia
Amarin Development has won a new contract to apply its formulation and manufacturing services to a neurological drug candidate developed by Acadia Pharmaceuticals
Archives for June 22, 2003
Containment facility broadens Solutia's scope
Applied chemistry company Solutia has completed the latest phase of a new containment facility to support the supply of highly potent active pharmaceutical ingredients
Policy continuity needed to speed up orphan drug development
While the procedure for designating drugs for orphan diseases has improved dramatically in the EU, further progress must be made, says EU biotech group
Nashai Biotech develops API-grade theaflavin
US company Nashai Biotech has developed a new process that preserves and protects theaflavins, compounds found in tea, when they are formulated into powders or liquids
Inpharmatica adds ADME with Arqule
UK informatics company Inpharmatica has added a whole new suite of ADME (absorption, distribution, metabolism and excretion) capabilities to its drug lead optimisation services with the purchase of a lab and intellectual property from Arqule.
Forum to mull UK labelling guidance
A conference on 1 July will provide an update on the UK Medicines and Healthcare products Regulatory Agency Best Practice Guidance on the Labelling and Packaging of Medicines
KS Avicenna offers biomanufacturing services
KS Avicenna, the Canadian unit of KS Biomedix of the UK, launched a newly expanded contract biopharmaceutical manufacturing facility in Canada, to service both North American and European clients, at the start of the BIO 2003 meeting, held 22-25 June...